CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising: https://ir.stemline…

MedMaven

MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising:

Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA Congress | Stemline Therapeutics
Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA Congress |…

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that positive clinical data from ELZONRISTM (tagraxofusp; SL-401) trials were presented at the 23rdCongress of the European Hematology Association (EHA) in Stockholm, Sweden.

Comments

Myeloproliferative Neoplasms MPN

FEATURED
COMMUNITY

Ask The Experts About COVID-19 and Myeloproliferative Neoplasms (MF - PV - ET)

PV, ET and MF are effectively treated during the COVID-19 pandemic - ask the experts about how best to manage your MPN.

MedMaven

Idasanutlin Treatment for Polycythemia Vera and Essential Thrombocytopenia

Idasanutlin is active in the treatment of PV and ET and is currently being evaluated in a global phase 2 trial.

MedMaven

Overview of Polycythemia Vera

Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.

Cancer Connect

MPN-RC 112 Clinical Trial Fails to Confirm Interferon Superiority in PV and ET

Research suggests conflicting results with Interferon treatment for polycythemia vera and essential thrombocythemia.

MedMaven

by

MedMaven

Thalidomide - Jakafi Combo A Novel Approach for Treatment of Myelofibrosis

Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts

MedMaven

by

EssayEver

Long Term Survival in Myelofibrosis Improved with Early Use of Jakafi®

In addition to improving long term survival Jakafi® improves MF caused fatigue, spleenomegaly and kidney function.

Cancer Connect

by

aliraza32415

MPN Research Foundation-PV Reporter-Cancer Connect Create Combined Community

Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients

Cancer Connect

Treatment of Myelofibrosis

CancerConnect - Treatment of Myelofibrosis

Cancer Connect

by

mkorn629

Jakafi Superior to Standard Therapy for Polycythemia Vera

Jakafi superior symptom control, delays phlebotomy, and improves outcomes for individuals with Polycythemia Vera.

Cancer Connect

Ask the Expert Advances in the Management of Myeloproliferative Neoplasms

Dr. Ruben Mesa, Mays Cancer Center answered questions about the management of polycythemia vera and myelofibrosis.

TraceyS